Scinovex
review Open AccessTop 1% cited

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity

Allergy · 2007 · Vol. 62(10) · pp. 1111–1118
Ewa Niżankowska‐MogilnickaGrażyna BochenekLucyna MastalerzMonika ŚwierczyńskaCésar PicadoGlenis ScaddingMarek L. KowalskiMałgorzata SetkowiczJohannes RingKnut BrockowClaus BachertStefan WöhrlBarbro DahlénA Szczeklik

Abstract

Aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two frequent clinical presentations of aspirin hypersensitivity are: aspirin-induced bronchial asthma/rhinosinusitis (AIA/R) and aspirin-induced urticaria/angioedema (AIU). The decisive diagnosis is based on provocation tests with aspirin, as the in vitro test does not hold diagnostic value as yet. Detailed protocols of oral, bronchial and nasal aspirin provocation tests are presented. Indications, contraindications for the tests, the rules of drug withdrawal and equipment are reviewed. Patient supervision and interpretations of the tests are proposed.

Drug-Induced Adverse ReactionsUrticaria and Related ConditionsAsthma and respiratory diseasesProvocation testAspirinMedicineGuidelineAllergyDermatologyImmunologyInternal medicinePathologyAlternative medicine

MeSH terms

Administration, OralAllergensAngioedemaAnti-Inflammatory Agents, Non-SteroidalAspirinAsthmaBronchial Provocation TestsDrug HypersensitivityEuropeHumansHypersensitivity, ImmediateNasal Provocation TestsSensitivity and SpecificityUrticariaPractice Guidelines as Topic
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity · Scinovex